| Financial Year |
March 31 2023 |
| Monetary Funds |
5,318,381,890.76 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
132,133,243.94 |
| Advances to Suppliers |
7,963,742.67 |
| Other Receivables |
14,808,141.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
5,833,086.07 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,287,321.76 |
| Total Current Assets |
5,475,574,340.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,979,737,415.50 |
| Investment Properties |
2,612,865.31 |
| Fixed Assetes |
9,830,478,703.30 |
| Under-construction Projects |
845,691,426.13 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
240,438,754.44 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
83,074,648.76 |
| Other Non-Current Assets |
31,992,422.86 |
| Sub-Total of Non-Current Assets |
15,741,017,265.52 |
| Total Assets |
21,216,591,605.79 |
| Short-Term Loans |
400,360,555.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
156,707,660.81 |
| Accounts Received In Advance |
2,625,805.37 |
| Employee Compensation Payable |
22,956,838.06 |
| Taxes Payable |
143,828,638.19 |
| Interest Payable |
-- |
| Dividend Payable |
114,164,517.93 |
| Other payables |
249,539,882.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
815,433,696.94 |
| Other Current Liabilities |
500,582,588.52 |
| Sub-Total of Current Liabilities |
2,292,035,665.48 |
| Long-term Loans |
5,908,487,090.00 |
| Bonds Payable |
748,614,788.35 |
| Long-Term Accounts Payable |
1,573,153.50 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
298,161,408.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,114,349,258.96 |
| Total Liabilities |
9,406,384,924.44 |
| Paid-In Capital(Or Share Stock) |
2,090,806,126.00 |
| Capital Surplus |
743,133,557.03 |
| Surplus Reserve |
1,373,056,469.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,107,792,552.93 |
| Minority Stockholder's Interest |
2,330,585,369.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,479,621,311.52 |
| Owner's Equity（Stockholder's Equity） |
11,810,206,681.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,216,591,605.79 |
